Rxsight Inc (RXST) returns
Rxsight returns over 5 years
$1,000 invested in Rxsight five years ago was worth $406.51 at the close on October 30, 2026, with dividends reinvested: an average return of -16.5% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -0.6% | — | $993.88 | -0.9% |
| 3 months | -19.9% | — | $800.99 | +2.1% |
| Year to date | -53.3% | — | $467.37 | +11.7% |
| 1 year | -43.3% | — | $566.94 | +12.4% |
| 3 years | -76.7% | -38.5% | $232.90 | +88.5% |
| 5 years | -59.3% | -16.5% | $406.51 | +76.0% |
Rxsight return by calendar year
| Year | RXST | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -53.3% | +11.7% | -65.0% |
| 2025 | -69.7% | +17.7% | -87.4% |
| 2024 | -14.7% | +24.9% | -39.6% |
| 2023 | +218.2% | +26.2% | +192.0% |
| 2022 | +12.6% | -18.2% | +30.8% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RXST financials
No forecast, no recommendation. This page describes Rxsight Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.